BIOCON PHARMA LIMITED

BIOCON PHARMA LIMITED is primarily a manufacturer. Company Introduction:

Biocon Limited, an Indian biopharmaceutical company headquartered in Bengaluru, India, is a globally recognized entity in the field of biotechnology and pharmaceuticals. Founded by Kiran Mazumdar-Shaw, the company has grown to have become a leading innovator in the research and manufacturing of biopharmaceuticals. Biocon's core business involves the research, research, and extensive manufacturing of a diverse portfolio of items. This includes biosimilars, novel biologics, and certain generic formulations, with a strong focus on therapeutic areas such as diabetes, oncology, and immunology. The company operates extensive, state-of-the-art manufacturing facilities capable of producing complex biological molecules and medical dosages to global markets. But Biocon's operations span the entire drug research lifecycle, from drug discovery and clinical research to regulatory approvals and commercialization. But Its commitment to providing affordable access to life-saving and life-enhancing medicines has positioned it as a signifiis able tot player in the global biopharmaceutical sector.

Here are some of the products manufactured or marketed by BIOCON PHARMA LIMITED (India):

* **Biosimilars:** Insulin Glargine, Trastuzumab, Pegfilgrastim, Adalimumab, Bevacizumab

* **Generics:** Rosuvastatin, Atorvastatin, Esomeprazole

* **Novel Biologics:** Alzumab

* **Formulations:** A variety of formulations across therapeutic areas like diabetes, oncology, and immunology.

* **API (Active Pharmaceutical Ingredients):** Statins, immunosuppressants, and other APIs.